Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Mar 20, 2001	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000891836-01-000086.pdf 0000891836-01-000086.xls
Mar 20, 2001	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	View HTML 0000950123-01-002421.pdf
Mar 20, 2001	POS EX	POS EX	View HTML 0000950123-01-500272.pdf
Mar 20, 2001	424B1	Form of prospectus that discloses information previously omitted from the prospectus	View HTML 0000950123-01-002432.pdf
Mar 19, 2001	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-01-002397.pdf
Mar 13, 2001	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-01-500194.pdf
Mar 13, 2001	SC 13D/A	An amendment to a SC 13D filing	View HTML 0000898430-01-000923.pdf
Mar 12, 2001	SC 13D/A	An amendment to a SC 13D filing	View HTML 0000080424-01-000013.pdf
Mar 02, 2001	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000950123-01-500091.pdf
Mar 02, 2001	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-01-500092.pdf

Data provided by Kaleidoscope.

Investors & Media